Healthcare associated infections from vascular access devices (VAD) have enormous and expensive consequences for patients, their families and the healthcare system. For this reason, strategies to prevent infection are the topic of ongoing research.Most evidence to date has focused on preventing infection during the device insertion procedure, with less attention given to methods of preventing infection in the following days, weeks or months. Bloodstream infections can occur from poor healthcare worker technique when administering medicine or other therapies, or occasionally from manufacturer-contaminated products.
AVATAR research tackles pre-insertion as well as post-insertion strategies for effective infection prevention. We undertake Randomised Controlled Trials (RCTs) to assess the cost-benefit to patients and the health system of implementing proven infection prevention strategies.